Immune制药

IMUX NASDAQ
13.55
+0.41
+3.12%
盘后: 13.15 -0.4 -2.95% 16:35 07/19 EDT
开盘
13.45
昨收
13.14
最高
13.84
最低
13.10
成交量
6.38万
成交均量(3M)
17.43万
52周最高
390.00
52周最低
6.04
换手率
0.64%
市值
1.35亿
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供Immune制药 IMUX股票价格,Immune制药股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Immunic, Inc., formerly Vital Therapies, Inc., is a clinical-stage biopharmaceutical company. The Company is focused on developing oral therapies for the treatment of chronic inflammatory and autoimmune diseases. The Company is developing three small molecule products: IMU-838 is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function. The Company’s lead development program, IMU-838, is in Phase II clinical development for ulcerative colitis and relapsing-remitting multiple sclerosis, with an additional Phase II trial in Crohn’s disease.
展开 >

最近浏览

名称
价格
涨跌幅